Latest filing published 13 Nov 2014 for TETRALOGIC PHARMACEUTICALS CORP, €16k.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -65.5%Entry US$4.52 · Close at T+365 US$1.56
- -37.3%Entry US$7.45 · Close at T+365 US$4.67
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Peter A. Meyers: trading record in brief
All filings by Peter A. Meyers on record concern Tetralogic Pharmaceuticals Corp. In total, 2 filings cover trades dated from 17 December 2013 to 12 November 2014.
No open-market sale appears; the market trades are 2 purchases worth €743k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2014, the count stands at 1 purchase and no sales.
Most recently, on 13 November 2014, the filings show an open-market purchase worth €16k in Tetralogic Pharmaceuticals Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Peter A. Meyers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$3.98Common StockSEC:0001192482-14-000236:0Canonical exit: 10 Feb 2015 (T+90)
- 142,857 shares@ US$7.00Common StockSEC:0001192482-13-000245:0Canonical exit: 17 Mar 2014 (T+90)
2 of 2 declarations